Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500115255) titled 'Construction of a multimodal database for high-risk populations of esophageal cancer based on a high-throughput polypeptide and metabolomics intelligent platform, and clinical application of a new early screening technology system' on Dec. 24, 2025.
Study Type: Diagnostic test
Study Design:
Diagnostic test for accuracy
Primary Sponsor: Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University
Condition:
esophageal cancer
Intervention:
Gold Standard:Gastroscopy with Pathological Examination
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2025-05-14
Target Sample Size:...